| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Placebo Effect | 85 | 2024 | 518 | 12.710 |
Why?
|
| Acupuncture Therapy | 58 | 2024 | 486 | 8.140 |
Why?
|
| Placebos | 62 | 2024 | 1668 | 8.120 |
Why?
|
| Irritable Bowel Syndrome | 25 | 2022 | 454 | 4.120 |
Why?
|
| Complementary Therapies | 34 | 2015 | 487 | 2.900 |
Why?
|
| Randomized Controlled Trials as Topic | 50 | 2024 | 10358 | 1.930 |
Why?
|
| Catechol O-Methyltransferase | 10 | 2019 | 251 | 1.860 |
Why?
|
| Acupuncture | 15 | 2014 | 90 | 1.620 |
Why?
|
| Low Back Pain | 17 | 2021 | 989 | 1.500 |
Why?
|
| Acupuncture Points | 13 | 2024 | 111 | 1.470 |
Why?
|
| Physician-Patient Relations | 20 | 2021 | 3267 | 1.370 |
Why?
|
| Informed Consent | 9 | 2017 | 1012 | 1.320 |
Why?
|
| Pain | 26 | 2022 | 5096 | 1.160 |
Why?
|
| Pain Measurement | 32 | 2022 | 3577 | 1.050 |
Why?
|
| Evidence-Based Medicine | 18 | 2017 | 3708 | 1.040 |
Why?
|
| Deception | 4 | 2020 | 101 | 1.030 |
Why?
|
| Acupuncture Analgesia | 11 | 2015 | 63 | 0.990 |
Why?
|
| Pharmacogenetics | 4 | 2020 | 677 | 0.990 |
Why?
|
| Herbal Medicine | 4 | 2013 | 37 | 0.920 |
Why?
|
| Research Subjects | 6 | 2012 | 249 | 0.920 |
Why?
|
| Medicine, Traditional | 5 | 2015 | 89 | 0.860 |
Why?
|
| Double-Blind Method | 45 | 2024 | 12450 | 0.840 |
Why?
|
| Methadone | 2 | 2023 | 322 | 0.840 |
Why?
|
| Research Design | 24 | 2022 | 6217 | 0.820 |
Why?
|
| Drugs, Chinese Herbal | 8 | 2016 | 148 | 0.810 |
Why?
|
| Clinical Trials as Topic | 18 | 2018 | 8051 | 0.800 |
Why?
|
| Biomedical Research | 10 | 2019 | 3463 | 0.790 |
Why?
|
| Amitriptyline | 3 | 2010 | 112 | 0.750 |
Why?
|
| Ethics, Medical | 9 | 2020 | 785 | 0.730 |
Why?
|
| Ethics, Research | 5 | 2017 | 177 | 0.730 |
Why?
|
| Medicine, Chinese Traditional | 7 | 2022 | 75 | 0.730 |
Why?
|
| Empathy | 6 | 2023 | 476 | 0.680 |
Why?
|
| Humans | 290 | 2024 | 768451 | 0.660 |
Why?
|
| Mental Healing | 4 | 2009 | 28 | 0.650 |
Why?
|
| Physicians | 11 | 2023 | 4615 | 0.650 |
Why?
|
| Pain Perception | 8 | 2020 | 198 | 0.620 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2019 | 162 | 0.610 |
Why?
|
| General Practitioners | 3 | 2019 | 103 | 0.610 |
Why?
|
| Controlled Clinical Trials as Topic | 4 | 2006 | 187 | 0.570 |
Why?
|
| Tai Ji | 4 | 2010 | 291 | 0.570 |
Why?
|
| Treatment Outcome | 60 | 2024 | 65409 | 0.570 |
Why?
|
| Brain Mapping | 21 | 2023 | 6740 | 0.550 |
Why?
|
| Bioethical Issues | 1 | 2018 | 120 | 0.540 |
Why?
|
| Brain | 25 | 2023 | 27438 | 0.540 |
Why?
|
| Bayes Theorem | 3 | 2020 | 2358 | 0.540 |
Why?
|
| Patients | 3 | 2009 | 909 | 0.530 |
Why?
|
| Somatosensory Cortex | 5 | 2020 | 516 | 0.530 |
Why?
|
| Professional-Patient Relations | 5 | 2020 | 727 | 0.530 |
Why?
|
| Hyperalgesia | 5 | 2021 | 527 | 0.520 |
Why?
|
| Beneficence | 2 | 2016 | 56 | 0.520 |
Why?
|
| Arthralgia | 5 | 2018 | 462 | 0.510 |
Why?
|
| Neck Pain | 3 | 2024 | 190 | 0.510 |
Why?
|
| Patient Selection | 6 | 2017 | 4266 | 0.500 |
Why?
|
| Attitude to Health | 9 | 2019 | 2030 | 0.500 |
Why?
|
| Antitussive Agents | 1 | 2015 | 18 | 0.500 |
Why?
|
| Ethics, Clinical | 1 | 2016 | 101 | 0.490 |
Why?
|
| Antidepressive Agents, Tricyclic | 3 | 2022 | 433 | 0.480 |
Why?
|
| Integrative Medicine | 4 | 2020 | 87 | 0.480 |
Why?
|
| Adult | 117 | 2024 | 223542 | 0.470 |
Why?
|
| Single-Blind Method | 10 | 2023 | 1585 | 0.470 |
Why?
|
| Needles | 4 | 2020 | 455 | 0.460 |
Why?
|
| Communication | 10 | 2020 | 3910 | 0.460 |
Why?
|
| Plant Extracts | 2 | 2010 | 499 | 0.460 |
Why?
|
| Pain Threshold | 8 | 2020 | 606 | 0.460 |
Why?
|
| Phytotherapy | 5 | 2015 | 298 | 0.450 |
Why?
|
| Prefrontal Cortex | 7 | 2021 | 2251 | 0.450 |
Why?
|
| Hot Flashes | 3 | 2022 | 330 | 0.450 |
Why?
|
| Perception | 3 | 2019 | 1207 | 0.450 |
Why?
|
| Medicine | 3 | 2019 | 946 | 0.440 |
Why?
|
| Physical Stimulation | 6 | 2019 | 517 | 0.430 |
Why?
|
| Anticonvulsants | 1 | 2023 | 1923 | 0.430 |
Why?
|
| Qi | 3 | 2008 | 15 | 0.430 |
Why?
|
| Anticipation, Psychological | 3 | 2017 | 86 | 0.430 |
Why?
|
| Patient Participation | 3 | 2017 | 1450 | 0.420 |
Why?
|
| Opioid-Related Disorders | 3 | 2023 | 2188 | 0.420 |
Why?
|
| Health Knowledge, Attitudes, Practice | 8 | 2020 | 4049 | 0.420 |
Why?
|
| Disclosure | 2 | 2017 | 750 | 0.410 |
Why?
|
| Analgesia | 5 | 2021 | 461 | 0.400 |
Why?
|
| Female | 136 | 2024 | 396943 | 0.400 |
Why?
|
| Vulvodynia | 2 | 2022 | 7 | 0.390 |
Why?
|
| Male | 123 | 2024 | 364781 | 0.390 |
Why?
|
| Ceremonial Behavior | 1 | 2011 | 17 | 0.380 |
Why?
|
| Hypnosis | 2 | 2009 | 84 | 0.380 |
Why?
|
| Therapeutic Touch | 1 | 2011 | 9 | 0.380 |
Why?
|
| Nerve Net | 7 | 2020 | 2362 | 0.370 |
Why?
|
| Cough | 1 | 2015 | 598 | 0.370 |
Why?
|
| Meditation | 4 | 2019 | 257 | 0.370 |
Why?
|
| Homeopathy | 4 | 2016 | 30 | 0.370 |
Why?
|
| Neural Pathways | 9 | 2020 | 3122 | 0.360 |
Why?
|
| Subcutaneous Tissue | 1 | 2011 | 132 | 0.360 |
Why?
|
| Research | 8 | 2021 | 1984 | 0.360 |
Why?
|
| Analgesics, Non-Narcotic | 3 | 2013 | 371 | 0.360 |
Why?
|
| Patient Satisfaction | 10 | 2016 | 3484 | 0.360 |
Why?
|
| Gyrus Cinguli | 4 | 2021 | 1136 | 0.360 |
Why?
|
| Clinical Medicine | 3 | 2009 | 145 | 0.350 |
Why?
|
| Albuterol | 1 | 2011 | 211 | 0.350 |
Why?
|
| Medicine, East Asian Traditional | 2 | 2007 | 17 | 0.350 |
Why?
|
| Middle Aged | 89 | 2024 | 223418 | 0.350 |
Why?
|
| Attitude of Health Personnel | 12 | 2023 | 3922 | 0.340 |
Why?
|
| Witchcraft | 1 | 2009 | 6 | 0.340 |
Why?
|
| Terminology as Topic | 2 | 2012 | 1539 | 0.340 |
Why?
|
| Religion and Medicine | 4 | 2019 | 161 | 0.340 |
Why?
|
| Dyspepsia | 2 | 2023 | 116 | 0.340 |
Why?
|
| Interviews as Topic | 9 | 2017 | 2733 | 0.340 |
Why?
|
| Christianity | 1 | 2009 | 50 | 0.330 |
Why?
|
| Relaxation Therapy | 4 | 2019 | 181 | 0.330 |
Why?
|
| Pain, Postoperative | 6 | 2022 | 1763 | 0.330 |
Why?
|
| Health Promotion | 3 | 2020 | 2215 | 0.330 |
Why?
|
| Osteoprotegerin | 1 | 2009 | 179 | 0.320 |
Why?
|
| Conditioning, Classical | 3 | 2018 | 370 | 0.320 |
Why?
|
| Synaptic Transmission | 1 | 2015 | 1173 | 0.320 |
Why?
|
| Ambulatory Care Facilities | 3 | 2011 | 941 | 0.320 |
Why?
|
| Minority Groups | 2 | 2013 | 1215 | 0.320 |
Why?
|
| Back Pain | 3 | 2024 | 547 | 0.310 |
Why?
|
| Plant Oils | 2 | 2021 | 199 | 0.310 |
Why?
|
| Antidepressive Agents | 3 | 2022 | 2913 | 0.310 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2010 | 153 | 0.300 |
Why?
|
| Electroacupuncture | 3 | 2017 | 66 | 0.300 |
Why?
|
| Reward | 3 | 2020 | 987 | 0.300 |
Why?
|
| Epilepsy | 1 | 2023 | 3324 | 0.290 |
Why?
|
| Cognition | 8 | 2019 | 7066 | 0.290 |
Why?
|
| Truth Disclosure | 1 | 2012 | 433 | 0.290 |
Why?
|
| Bronchodilator Agents | 1 | 2011 | 519 | 0.290 |
Why?
|
| Indians, North American | 1 | 2011 | 354 | 0.290 |
Why?
|
| Peer Review | 1 | 2009 | 217 | 0.290 |
Why?
|
| Yin-Yang | 2 | 2004 | 10 | 0.290 |
Why?
|
| History, 19th Century | 7 | 2012 | 716 | 0.280 |
Why?
|
| Magnetic Resonance Imaging | 36 | 2024 | 36840 | 0.280 |
Why?
|
| Concept Formation | 1 | 2008 | 162 | 0.280 |
Why?
|
| History, 18th Century | 7 | 2009 | 207 | 0.280 |
Why?
|
| Pruritus | 3 | 2015 | 380 | 0.270 |
Why?
|
| Attention | 3 | 2013 | 2423 | 0.270 |
Why?
|
| Psychotropic Drugs | 1 | 2012 | 888 | 0.270 |
Why?
|
| Neovascularization, Physiologic | 4 | 2016 | 1369 | 0.270 |
Why?
|
| Publication Bias | 2 | 2011 | 160 | 0.260 |
Why?
|
| Office Visits | 4 | 2020 | 596 | 0.260 |
Why?
|
| Panax | 1 | 2005 | 28 | 0.260 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2019 | 16029 | 0.260 |
Why?
|
| Social Support | 3 | 2012 | 2195 | 0.250 |
Why?
|
| Pilot Projects | 15 | 2022 | 8730 | 0.250 |
Why?
|
| Sensation | 3 | 2015 | 337 | 0.250 |
Why?
|
| Skin | 3 | 2023 | 4520 | 0.250 |
Why?
|
| Culture | 2 | 2008 | 624 | 0.250 |
Why?
|
| Analgesics, Opioid | 5 | 2023 | 3837 | 0.250 |
Why?
|
| Comparative Effectiveness Research | 1 | 2011 | 712 | 0.250 |
Why?
|
| Prejudice | 1 | 2009 | 574 | 0.250 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2007 | 247 | 0.250 |
Why?
|
| Periodicals as Topic | 3 | 2012 | 1468 | 0.250 |
Why?
|
| Arm Injuries | 2 | 2022 | 156 | 0.240 |
Why?
|
| Cross-Over Studies | 7 | 2014 | 2103 | 0.240 |
Why?
|
| Menopause | 3 | 2022 | 1651 | 0.240 |
Why?
|
| Touch Perception | 2 | 2020 | 106 | 0.240 |
Why?
|
| Holistic Health | 2 | 2001 | 48 | 0.240 |
Why?
|
| Cerebral Cortex | 7 | 2023 | 5827 | 0.240 |
Why?
|
| Patulin | 1 | 2004 | 1 | 0.240 |
Why?
|
| Patient Education as Topic | 4 | 2012 | 2339 | 0.240 |
Why?
|
| Young Adult | 38 | 2021 | 60045 | 0.240 |
Why?
|
| History, 20th Century | 9 | 2012 | 2772 | 0.230 |
Why?
|
| Neuralgia | 2 | 2023 | 620 | 0.230 |
Why?
|
| Constipation | 2 | 2019 | 570 | 0.230 |
Why?
|
| Public Health | 3 | 2020 | 2693 | 0.230 |
Why?
|
| Osteoarthritis, Knee | 4 | 2018 | 1252 | 0.220 |
Why?
|
| Common Cold | 1 | 2004 | 63 | 0.220 |
Why?
|
| Peripheral Nerves | 1 | 2007 | 492 | 0.220 |
Why?
|
| Infertility, Female | 1 | 2010 | 764 | 0.220 |
Why?
|
| Quality of Life | 12 | 2023 | 13497 | 0.220 |
Why?
|
| Diabetic Neuropathies | 1 | 2007 | 411 | 0.220 |
Why?
|
| Neurosciences | 1 | 2008 | 385 | 0.210 |
Why?
|
| Arm | 4 | 2011 | 590 | 0.210 |
Why?
|
| Chiropractic | 2 | 2002 | 39 | 0.210 |
Why?
|
| Internationality | 1 | 2008 | 1007 | 0.210 |
Why?
|
| Fatigue | 2 | 2022 | 1556 | 0.210 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2022 | 1097 | 0.200 |
Why?
|
| Gastroesophageal Reflux | 3 | 2015 | 833 | 0.200 |
Why?
|
| Chronic Disease | 11 | 2019 | 9382 | 0.200 |
Why?
|
| Family | 2 | 2019 | 3208 | 0.190 |
Why?
|
| Nonverbal Communication | 1 | 2022 | 62 | 0.190 |
Why?
|
| Risk Assessment | 7 | 2019 | 24311 | 0.190 |
Why?
|
| Interpersonal Relations | 1 | 2009 | 1439 | 0.190 |
Why?
|
| Neurotransmitter Agents | 2 | 2015 | 666 | 0.180 |
Why?
|
| Analysis of Variance | 7 | 2021 | 6242 | 0.180 |
Why?
|
| Nausea | 3 | 2012 | 682 | 0.180 |
Why?
|
| Lateral Thalamic Nuclei | 1 | 2020 | 9 | 0.180 |
Why?
|
| Dopamine | 3 | 2024 | 1616 | 0.180 |
Why?
|
| Penicillins | 1 | 2004 | 405 | 0.180 |
Why?
|
| Genetic Variation | 2 | 2015 | 6610 | 0.180 |
Why?
|
| Atropine | 2 | 2019 | 244 | 0.180 |
Why?
|
| Ventral Thalamic Nuclei | 1 | 2020 | 43 | 0.180 |
Why?
|
| China | 7 | 2022 | 2398 | 0.180 |
Why?
|
| Injections, Intramuscular | 1 | 2022 | 557 | 0.180 |
Why?
|
| Severity of Illness Index | 8 | 2018 | 15965 | 0.180 |
Why?
|
| Motivation | 3 | 2022 | 2034 | 0.170 |
Why?
|
| Colonic Diseases, Functional | 1 | 1999 | 39 | 0.170 |
Why?
|
| Agnosia | 1 | 2020 | 66 | 0.170 |
Why?
|
| Models, Theoretical | 2 | 2018 | 3590 | 0.170 |
Why?
|
| Data Interpretation, Statistical | 4 | 2010 | 2705 | 0.170 |
Why?
|
| Blood Sedimentation | 1 | 2020 | 235 | 0.170 |
Why?
|
| Analgesics | 4 | 2021 | 1070 | 0.160 |
Why?
|
| Regression Analysis | 6 | 2014 | 6353 | 0.160 |
Why?
|
| Nurse-Patient Relations | 1 | 2019 | 100 | 0.160 |
Why?
|
| Catastrophization | 2 | 2022 | 349 | 0.160 |
Why?
|
| Asthma | 4 | 2014 | 6274 | 0.160 |
Why?
|
| Drug Therapy | 1 | 2002 | 504 | 0.160 |
Why?
|
| Neurofeedback | 1 | 2019 | 50 | 0.160 |
Why?
|
| Academic Medical Centers | 4 | 2016 | 2785 | 0.160 |
Why?
|
| Gastrointestinal Agents | 2 | 2017 | 510 | 0.160 |
Why?
|
| Pregnancy Outcome | 1 | 2010 | 2959 | 0.160 |
Why?
|
| United States | 34 | 2017 | 73121 | 0.160 |
Why?
|
| alpha-Tocopherol | 1 | 2019 | 126 | 0.160 |
Why?
|
| Hospitals, Urban | 2 | 2015 | 501 | 0.160 |
Why?
|
| Philosophy | 1 | 2019 | 69 | 0.160 |
Why?
|
| Cocaine-Related Disorders | 1 | 2002 | 461 | 0.160 |
Why?
|
| Food, Organic | 1 | 1998 | 34 | 0.150 |
Why?
|
| Aged | 42 | 2024 | 171520 | 0.150 |
Why?
|
| Cues | 5 | 2014 | 884 | 0.150 |
Why?
|
| Equipment and Supplies | 1 | 2000 | 273 | 0.150 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2020 | 637 | 0.140 |
Why?
|
| Hot Temperature | 4 | 2015 | 1439 | 0.140 |
Why?
|
| Personal Autonomy | 2 | 2012 | 315 | 0.140 |
Why?
|
| Endothelial Cells | 4 | 2016 | 3586 | 0.140 |
Why?
|
| Endothelial Growth Factors | 1 | 1999 | 674 | 0.140 |
Why?
|
| Massage | 4 | 2015 | 86 | 0.140 |
Why?
|
| Emigrants and Immigrants | 2 | 2015 | 548 | 0.140 |
Why?
|
| Tonsillectomy | 2 | 2019 | 278 | 0.140 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2015 | 3237 | 0.140 |
Why?
|
| Stress, Psychological | 4 | 2019 | 4538 | 0.140 |
Why?
|
| Diclofenac | 1 | 2017 | 69 | 0.140 |
Why?
|
| Xerostomia | 1 | 2017 | 94 | 0.140 |
Why?
|
| Genetic Association Studies | 4 | 2019 | 2742 | 0.140 |
Why?
|
| Paternalism | 2 | 2012 | 49 | 0.140 |
Why?
|
| Plants, Medicinal | 2 | 2010 | 167 | 0.140 |
Why?
|
| Germany | 2 | 2010 | 882 | 0.140 |
Why?
|
| Lymphokines | 1 | 1999 | 927 | 0.140 |
Why?
|
| Ephrin-B2 | 1 | 2016 | 40 | 0.130 |
Why?
|
| Conversion Disorder | 1 | 2019 | 202 | 0.130 |
Why?
|
| Receptor, EphB4 | 1 | 2016 | 39 | 0.130 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1998 | 361 | 0.130 |
Why?
|
| Medical Oncology | 2 | 2019 | 2347 | 0.130 |
Why?
|
| Basal Ganglia | 1 | 2019 | 555 | 0.130 |
Why?
|
| Acupressure | 2 | 2010 | 16 | 0.130 |
Why?
|
| Outpatients | 1 | 2004 | 1607 | 0.130 |
Why?
|
| Curriculum | 3 | 2015 | 3778 | 0.130 |
Why?
|
| Transcranial Magnetic Stimulation | 3 | 2022 | 1489 | 0.130 |
Why?
|
| Epilepsies, Partial | 1 | 2019 | 435 | 0.130 |
Why?
|
| Peanut Hypersensitivity | 1 | 2019 | 219 | 0.130 |
Why?
|
| Thinking | 1 | 2019 | 320 | 0.130 |
Why?
|
| Clonidine | 1 | 2016 | 170 | 0.130 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2016 | 93 | 0.130 |
Why?
|
| Cyclosporine | 1 | 2018 | 780 | 0.120 |
Why?
|
| Infertility | 1 | 2022 | 654 | 0.120 |
Why?
|
| Acute Disease | 3 | 2007 | 7246 | 0.120 |
Why?
|
| Diagnostic Self Evaluation | 2 | 2020 | 227 | 0.120 |
Why?
|
| Serum | 1 | 2016 | 208 | 0.120 |
Why?
|
| Microvessels | 2 | 2016 | 586 | 0.120 |
Why?
|
| Depressive Disorder, Major | 3 | 2024 | 4816 | 0.120 |
Why?
|
| Opiate Substitution Treatment | 1 | 2019 | 446 | 0.120 |
Why?
|
| Dietary Supplements | 6 | 2019 | 3445 | 0.120 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2016 | 217 | 0.120 |
Why?
|
| Interdisciplinary Communication | 4 | 2008 | 937 | 0.120 |
Why?
|
| Parietal Lobe | 2 | 2012 | 866 | 0.120 |
Why?
|
| Genetics | 1 | 2015 | 114 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2019 | 2279 | 0.120 |
Why?
|
| Qualitative Research | 4 | 2019 | 3115 | 0.120 |
Why?
|
| Cardiovascular Diseases | 4 | 2019 | 15638 | 0.120 |
Why?
|
| Narcotic Antagonists | 1 | 2019 | 590 | 0.120 |
Why?
|
| Periaqueductal Gray | 2 | 2015 | 111 | 0.120 |
Why?
|
| Clinical Protocols | 4 | 2017 | 1444 | 0.110 |
Why?
|
| Tacrolimus | 1 | 2018 | 750 | 0.110 |
Why?
|
| Clinical Competence | 4 | 2015 | 4841 | 0.110 |
Why?
|
| Neck Muscles | 1 | 2014 | 100 | 0.110 |
Why?
|
| Anxiety | 7 | 2022 | 4655 | 0.110 |
Why?
|
| Awareness | 2 | 2015 | 654 | 0.110 |
Why?
|
| Medicine, Ayurvedic | 1 | 2013 | 37 | 0.110 |
Why?
|
| Waiting Lists | 2 | 2009 | 778 | 0.110 |
Why?
|
| Evidence-Based Practice | 1 | 2018 | 500 | 0.110 |
Why?
|
| Decision Making | 4 | 2012 | 3961 | 0.110 |
Why?
|
| Autonomic Nervous System | 1 | 2019 | 709 | 0.110 |
Why?
|
| Headache | 1 | 2022 | 1260 | 0.110 |
Why?
|
| Allergens | 2 | 2019 | 1445 | 0.110 |
Why?
|
| Personality | 2 | 2014 | 558 | 0.110 |
Why?
|
| Models, Psychological | 1 | 2018 | 835 | 0.110 |
Why?
|
| Interprofessional Relations | 2 | 2016 | 997 | 0.110 |
Why?
|
| Politics | 2 | 2012 | 821 | 0.110 |
Why?
|
| Research Support as Topic | 2 | 2008 | 699 | 0.110 |
Why?
|
| Carpal Tunnel Syndrome | 1 | 2017 | 304 | 0.110 |
Why?
|
| Physical Fitness | 2 | 2008 | 744 | 0.110 |
Why?
|
| Hypnotics and Sedatives | 1 | 2021 | 1188 | 0.110 |
Why?
|
| Reproducibility of Results | 8 | 2010 | 20231 | 0.110 |
Why?
|
| Angiogenesis Inducing Agents | 2 | 2012 | 254 | 0.110 |
Why?
|
| Desensitization, Immunologic | 1 | 2019 | 563 | 0.110 |
Why?
|
| Dermatitis, Atopic | 3 | 2015 | 734 | 0.110 |
Why?
|
| Shoulder Pain | 1 | 2014 | 152 | 0.110 |
Why?
|
| Anisotropy | 2 | 2020 | 1296 | 0.110 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1999 | 716 | 0.110 |
Why?
|
| Photic Stimulation | 3 | 2014 | 2005 | 0.110 |
Why?
|
| Postoperative Care | 1 | 2019 | 1481 | 0.110 |
Why?
|
| Drug Labeling | 2 | 2014 | 250 | 0.100 |
Why?
|
| Music Therapy | 1 | 2014 | 111 | 0.100 |
Why?
|
| Neoplasms | 6 | 2019 | 22386 | 0.100 |
Why?
|
| Sensory Thresholds | 2 | 2020 | 377 | 0.100 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2018 | 1193 | 0.100 |
Why?
|
| Suggestion | 3 | 2019 | 21 | 0.100 |
Why?
|
| Adolescent | 21 | 2022 | 89168 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1089 | 0.100 |
Why?
|
| Reference Values | 3 | 2010 | 4941 | 0.100 |
Why?
|
| Community Health Centers | 1 | 2015 | 470 | 0.100 |
Why?
|
| Schools, Medical | 1 | 1998 | 881 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2015 | 23638 | 0.100 |
Why?
|
| Psychomotor Performance | 1 | 2020 | 1894 | 0.100 |
Why?
|
| Torture | 1 | 2012 | 69 | 0.100 |
Why?
|
| Nervous System | 1 | 2015 | 547 | 0.100 |
Why?
|
| Cooperative Behavior | 3 | 2010 | 1514 | 0.100 |
Why?
|
| Amino Acid Substitution | 2 | 2014 | 1744 | 0.100 |
Why?
|
| Attitude | 1 | 2016 | 773 | 0.100 |
Why?
|
| Neuronal Plasticity | 1 | 2020 | 1448 | 0.090 |
Why?
|
| Orthopedic Procedures | 1 | 2021 | 1280 | 0.090 |
Why?
|
| Libraries | 1 | 2010 | 21 | 0.090 |
Why?
|
| Meridians | 1 | 2010 | 7 | 0.090 |
Why?
|
| Health Personnel | 3 | 2015 | 3384 | 0.090 |
Why?
|
| Hippocampus | 3 | 2014 | 3783 | 0.090 |
Why?
|
| Alpha Rhythm | 1 | 2011 | 111 | 0.090 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2020 | 3763 | 0.090 |
Why?
|
| Medicine, Korean Traditional | 1 | 2010 | 3 | 0.090 |
Why?
|
| Visual Perception | 1 | 2019 | 1406 | 0.090 |
Why?
|
| Moxibustion | 1 | 2010 | 8 | 0.090 |
Why?
|
| Reproductive Techniques | 1 | 2010 | 41 | 0.090 |
Why?
|
| Meta-Analysis as Topic | 3 | 2014 | 1364 | 0.090 |
Why?
|
| Rest | 4 | 2019 | 952 | 0.090 |
Why?
|
| Drug Contamination | 1 | 2011 | 152 | 0.090 |
Why?
|
| Mentha piperita | 2 | 2021 | 18 | 0.090 |
Why?
|
| Thigh | 1 | 2011 | 239 | 0.090 |
Why?
|
| Metals, Heavy | 1 | 2011 | 149 | 0.090 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2018 | 1814 | 0.080 |
Why?
|
| Tumor Necrosis Factors | 1 | 2009 | 109 | 0.080 |
Why?
|
| History, 16th Century | 1 | 2009 | 70 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2023 | 6278 | 0.080 |
Why?
|
| Health Care Surveys | 7 | 2011 | 2437 | 0.080 |
Why?
|
| Models, Neurological | 1 | 2018 | 1784 | 0.080 |
Why?
|
| Financing, Organized | 2 | 2008 | 206 | 0.080 |
Why?
|
| Motor Cortex | 2 | 2007 | 1015 | 0.080 |
Why?
|
| Vulnerable Populations | 1 | 2015 | 717 | 0.080 |
Why?
|
| Education, Medical | 2 | 2016 | 1742 | 0.080 |
Why?
|
| Electric Stimulation | 2 | 2011 | 1743 | 0.080 |
Why?
|
| Acetaminophen | 1 | 2013 | 556 | 0.080 |
Why?
|
| Administration, Oral | 3 | 2019 | 4041 | 0.080 |
Why?
|
| Consciousness | 1 | 2014 | 603 | 0.080 |
Why?
|
| Myocardial Ischemia | 1 | 1999 | 2139 | 0.080 |
Why?
|
| Social Identification | 1 | 2009 | 108 | 0.080 |
Why?
|
| Rehabilitation | 1 | 2010 | 131 | 0.080 |
Why?
|
| Documentation | 1 | 2015 | 913 | 0.080 |
Why?
|
| Touch | 1 | 2011 | 316 | 0.080 |
Why?
|
| Republic of Korea | 2 | 2023 | 587 | 0.080 |
Why?
|
| Pesticides | 1 | 2011 | 299 | 0.080 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 3854 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2015 | 3520 | 0.080 |
Why?
|
| Illusions | 1 | 2008 | 61 | 0.080 |
Why?
|
| France | 1 | 2009 | 497 | 0.080 |
Why?
|
| Brain Concussion | 1 | 2020 | 1430 | 0.080 |
Why?
|
| Consensus | 1 | 2018 | 3207 | 0.080 |
Why?
|
| Forearm | 2 | 2012 | 428 | 0.080 |
Why?
|
| Lidocaine | 3 | 2018 | 545 | 0.070 |
Why?
|
| Pediatrics | 1 | 2023 | 3622 | 0.070 |
Why?
|
| Mind-Body Relations, Metaphysical | 1 | 2008 | 36 | 0.070 |
Why?
|
| Naturopathy | 2 | 2009 | 13 | 0.070 |
Why?
|
| Emotions | 3 | 2022 | 2773 | 0.070 |
Why?
|
| Pregnancy | 1 | 2010 | 30179 | 0.070 |
Why?
|
| Decision Making, Organizational | 1 | 2008 | 136 | 0.070 |
Why?
|
| Survivors | 2 | 2023 | 2381 | 0.070 |
Why?
|
| Organizations | 1 | 2008 | 172 | 0.070 |
Why?
|
| Shoulder Joint | 1 | 2014 | 749 | 0.070 |
Why?
|
| Alzheimer Disease | 2 | 2019 | 8721 | 0.070 |
Why?
|
| Social Values | 1 | 2008 | 225 | 0.070 |
Why?
|
| Delirium | 1 | 2019 | 1694 | 0.070 |
Why?
|
| False Positive Reactions | 1 | 2009 | 962 | 0.070 |
Why?
|
| Sociology, Medical | 1 | 2007 | 62 | 0.070 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2007 | 239 | 0.070 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 5495 | 0.070 |
Why?
|
| Delivery of Health Care | 1 | 2005 | 5367 | 0.070 |
Why?
|
| Self Report | 3 | 2019 | 3771 | 0.070 |
Why?
|
| Hemiplegia | 1 | 2007 | 136 | 0.070 |
Why?
|
| Professional Role | 1 | 2009 | 316 | 0.070 |
Why?
|
| Rheumatology | 2 | 2010 | 619 | 0.070 |
Why?
|
| Licensure | 3 | 2002 | 127 | 0.070 |
Why?
|
| Social Isolation | 1 | 2009 | 369 | 0.070 |
Why?
|
| Personality Inventory | 1 | 2009 | 1019 | 0.070 |
Why?
|
| Leg | 1 | 2011 | 1089 | 0.070 |
Why?
|
| Frontal Lobe | 1 | 2012 | 1427 | 0.070 |
Why?
|
| Forced Expiratory Volume | 1 | 2011 | 1820 | 0.070 |
Why?
|
| Stress, Mechanical | 1 | 2011 | 1680 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 1996 | 2179 | 0.070 |
Why?
|
| Injections, Intradermal | 1 | 2006 | 116 | 0.060 |
Why?
|
| Citalopram | 1 | 2009 | 403 | 0.060 |
Why?
|
| Phototherapy | 1 | 2009 | 369 | 0.060 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2009 | 490 | 0.060 |
Why?
|
| Social Perception | 1 | 2009 | 434 | 0.060 |
Why?
|
| Genotype | 3 | 2019 | 13047 | 0.060 |
Why?
|
| Time Factors | 7 | 2018 | 40271 | 0.060 |
Why?
|
| Galvanic Skin Response | 1 | 2007 | 359 | 0.060 |
Why?
|
| Fibromyalgia | 1 | 2010 | 406 | 0.060 |
Why?
|
| Quality Control | 2 | 2011 | 835 | 0.060 |
Why?
|
| Musculoskeletal Diseases | 1 | 2011 | 601 | 0.060 |
Why?
|
| Tablets | 1 | 2006 | 149 | 0.060 |
Why?
|
| Vision, Ocular | 1 | 2009 | 458 | 0.060 |
Why?
|
| Primary Health Care | 2 | 2019 | 4737 | 0.060 |
Why?
|
| Parahippocampal Gyrus | 1 | 2006 | 118 | 0.060 |
Why?
|
| Japan | 2 | 2023 | 1418 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2023 | 13708 | 0.060 |
Why?
|
| Advisory Committees | 1 | 2009 | 797 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2018 | 4213 | 0.060 |
Why?
|
| Internet | 2 | 2015 | 3123 | 0.060 |
Why?
|
| Health Surveys | 2 | 2016 | 4056 | 0.060 |
Why?
|
| Parkinson Disease | 1 | 2019 | 2891 | 0.060 |
Why?
|
| Prospective Studies | 9 | 2020 | 54914 | 0.060 |
Why?
|
| Abortion, Spontaneous | 1 | 2010 | 539 | 0.060 |
Why?
|
| Control Groups | 2 | 2010 | 107 | 0.060 |
Why?
|
| Pons | 1 | 2006 | 242 | 0.060 |
Why?
|
| Paresis | 1 | 2005 | 177 | 0.060 |
Why?
|
| Mind-Body Therapies | 3 | 2016 | 291 | 0.060 |
Why?
|
| Anesthetics, Local | 3 | 2018 | 1005 | 0.060 |
Why?
|
| Health Behavior | 1 | 2016 | 2649 | 0.060 |
Why?
|
| Behavioral Symptoms | 1 | 2006 | 188 | 0.060 |
Why?
|
| Artificial Intelligence | 1 | 2019 | 2659 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2009 | 2286 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2018 | 10784 | 0.060 |
Why?
|
| Video Recording | 1 | 2009 | 974 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2863 | 0.060 |
Why?
|
| Bell Palsy | 1 | 2004 | 39 | 0.060 |
Why?
|
| Refugees | 1 | 2012 | 612 | 0.060 |
Why?
|
| Task Performance and Analysis | 1 | 2008 | 771 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3794 | 0.060 |
Why?
|
| Blood Flow Velocity | 1 | 2007 | 1377 | 0.050 |
Why?
|
| Psychometrics | 3 | 2012 | 3072 | 0.050 |
Why?
|
| Psychiatry | 1 | 2015 | 1714 | 0.050 |
Why?
|
| Blood Glucose | 3 | 2016 | 6429 | 0.050 |
Why?
|
| Patient Dropouts | 2 | 2019 | 411 | 0.050 |
Why?
|
| Public Opinion | 1 | 2007 | 487 | 0.050 |
Why?
|
| Cross-Sectional Studies | 8 | 2023 | 26351 | 0.050 |
Why?
|
| Headache Disorders | 1 | 2005 | 152 | 0.050 |
Why?
|
| Depressive Disorder | 1 | 2015 | 3738 | 0.050 |
Why?
|
| Hand Strength | 1 | 2006 | 465 | 0.050 |
Why?
|
| Drug Discovery | 1 | 2010 | 1062 | 0.050 |
Why?
|
| Kidney Transplantation | 1 | 2018 | 4285 | 0.050 |
Why?
|
| England | 1 | 2004 | 533 | 0.050 |
Why?
|
| Exanthema | 1 | 2007 | 504 | 0.050 |
Why?
|
| Parents | 1 | 2016 | 3596 | 0.050 |
Why?
|
| Microcirculation | 1 | 2007 | 1282 | 0.050 |
Why?
|
| Aspirin | 1 | 2014 | 3139 | 0.050 |
Why?
|
| Patient-Centered Care | 2 | 2009 | 1439 | 0.050 |
Why?
|
| Vomiting | 2 | 2010 | 655 | 0.050 |
Why?
|
| Skin Temperature | 1 | 2022 | 96 | 0.050 |
Why?
|
| Functional Laterality | 1 | 2008 | 2268 | 0.050 |
Why?
|
| Diet Fads | 1 | 2001 | 14 | 0.050 |
Why?
|
| Empiricism | 1 | 2001 | 7 | 0.050 |
Why?
|
| Morphine | 1 | 2006 | 658 | 0.050 |
Why?
|
| Depression | 1 | 2021 | 8235 | 0.050 |
Why?
|
| Health Status | 2 | 2015 | 4096 | 0.050 |
Why?
|
| Vestibule, Labyrinth | 1 | 2004 | 235 | 0.050 |
Why?
|
| History, Ancient | 1 | 2002 | 215 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2005 | 879 | 0.050 |
Why?
|
| Spiritual Therapies | 1 | 2002 | 60 | 0.050 |
Why?
|
| Aged, 80 and over | 10 | 2018 | 59680 | 0.050 |
Why?
|
| Echo-Planar Imaging | 1 | 2006 | 669 | 0.050 |
Why?
|
| Linear Models | 2 | 2009 | 5880 | 0.050 |
Why?
|
| Receptors, Opioid | 1 | 2001 | 145 | 0.050 |
Why?
|
| Internal Medicine | 1 | 2008 | 1056 | 0.050 |
Why?
|
| Neuropsychological Tests | 2 | 2018 | 7134 | 0.050 |
Why?
|
| Migraine Disorders | 1 | 2014 | 1713 | 0.050 |
Why?
|
| Vestibular Diseases | 1 | 2004 | 232 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2011 | 5995 | 0.050 |
Why?
|
| Magnetics | 1 | 2004 | 599 | 0.050 |
Why?
|
| Visual Cortex | 1 | 2009 | 1112 | 0.050 |
Why?
|
| Longitudinal Studies | 3 | 2020 | 14766 | 0.040 |
Why?
|
| Homeostasis | 1 | 2011 | 3351 | 0.040 |
Why?
|
| Upper Extremity | 1 | 2005 | 682 | 0.040 |
Why?
|
| Professional Practice | 1 | 2002 | 314 | 0.040 |
Why?
|
| Referral and Consultation | 3 | 2018 | 3629 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 2005 | 1158 | 0.040 |
Why?
|
| Child | 9 | 2023 | 80863 | 0.040 |
Why?
|
| Vitalism | 1 | 1998 | 2 | 0.040 |
Why?
|
| Nature | 1 | 1998 | 15 | 0.040 |
Why?
|
| Spiritualism | 1 | 1998 | 18 | 0.040 |
Why?
|
| Postural Balance | 1 | 2004 | 638 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2002 | 794 | 0.040 |
Why?
|
| Otitis Media with Effusion | 1 | 2000 | 115 | 0.040 |
Why?
|
| Maryland | 1 | 2019 | 277 | 0.040 |
Why?
|
| Persuasive Communication | 1 | 2019 | 58 | 0.040 |
Why?
|
| Iatrogenic Disease | 1 | 2022 | 552 | 0.040 |
Why?
|
| Oxygen | 3 | 2018 | 4269 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2009 | 2737 | 0.040 |
Why?
|
| Mental Health | 1 | 2013 | 3271 | 0.040 |
Why?
|
| Cerebellum | 1 | 2006 | 1515 | 0.040 |
Why?
|
| Carbidopa | 1 | 2018 | 30 | 0.040 |
Why?
|
| Retrospective Studies | 8 | 2022 | 81834 | 0.040 |
Why?
|
| Cognitive Reserve | 1 | 2019 | 92 | 0.040 |
Why?
|
| Sweden | 1 | 2021 | 1382 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1999 | 750 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2016 | 12242 | 0.040 |
Why?
|
| Association | 1 | 2018 | 53 | 0.040 |
Why?
|
| Adaptation, Psychological | 3 | 2014 | 2665 | 0.040 |
Why?
|
| Facial Expression | 1 | 2022 | 515 | 0.040 |
Why?
|
| Health Policy | 1 | 2010 | 2699 | 0.040 |
Why?
|
| beta Carotene | 1 | 2019 | 523 | 0.040 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2018 | 359 | 0.040 |
Why?
|
| Observer Variation | 1 | 2004 | 2622 | 0.040 |
Why?
|
| Religion | 1 | 2001 | 377 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2018 | 9066 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2023 | 21156 | 0.040 |
Why?
|
| Back | 1 | 1997 | 64 | 0.040 |
Why?
|
| Cell Adhesion | 2 | 2015 | 3103 | 0.040 |
Why?
|
| Levodopa | 1 | 2018 | 223 | 0.030 |
Why?
|
| Catecholamines | 1 | 2018 | 390 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2022 | 22293 | 0.030 |
Why?
|
| Dopamine Agents | 1 | 2018 | 190 | 0.030 |
Why?
|
| Stem Cells | 1 | 2010 | 3538 | 0.030 |
Why?
|
| Taste | 1 | 2018 | 191 | 0.030 |
Why?
|
| Data Mining | 1 | 2022 | 561 | 0.030 |
Why?
|
| Orthostatic Intolerance | 1 | 2016 | 22 | 0.030 |
Why?
|
| Alleles | 2 | 2019 | 6890 | 0.030 |
Why?
|
| Median Nerve | 1 | 2017 | 133 | 0.030 |
Why?
|
| Cholesterol | 1 | 2005 | 2910 | 0.030 |
Why?
|
| Diet, Vegetarian | 1 | 1998 | 181 | 0.030 |
Why?
|
| Follow-Up Studies | 6 | 2021 | 39430 | 0.030 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2017 | 300 | 0.030 |
Why?
|
| Haloperidol | 1 | 2018 | 394 | 0.030 |
Why?
|
| Science | 1 | 1998 | 239 | 0.030 |
Why?
|
| Awards and Prizes | 1 | 2020 | 365 | 0.030 |
Why?
|
| Capsules | 1 | 2016 | 193 | 0.030 |
Why?
|
| Wind | 1 | 2015 | 44 | 0.030 |
Why?
|
| Government Programs | 2 | 2008 | 278 | 0.030 |
Why?
|
| Self Care | 1 | 2001 | 798 | 0.030 |
Why?
|
| Neural Conduction | 1 | 2017 | 443 | 0.030 |
Why?
|
| Urban Population | 2 | 2015 | 2047 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2018 | 643 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2022 | 1070 | 0.030 |
Why?
|
| Polysomnography | 1 | 2022 | 1864 | 0.030 |
Why?
|
| Wrist | 1 | 2017 | 232 | 0.030 |
Why?
|
| Positron-Emission Tomography | 3 | 2024 | 6657 | 0.030 |
Why?
|
| Antacids | 1 | 2015 | 94 | 0.030 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2016 | 205 | 0.030 |
Why?
|
| Physician's Role | 1 | 2002 | 927 | 0.030 |
Why?
|
| Subliminal Stimulation | 1 | 2014 | 8 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2001 | 1575 | 0.030 |
Why?
|
| Norway | 1 | 2016 | 501 | 0.030 |
Why?
|
| Vietnam | 1 | 2015 | 416 | 0.030 |
Why?
|
| Organizational Innovation | 2 | 2008 | 540 | 0.030 |
Why?
|
| Perceptual Masking | 1 | 2014 | 90 | 0.030 |
Why?
|
| Personality Tests | 1 | 2014 | 80 | 0.030 |
Why?
|
| Histamine H2 Antagonists | 1 | 2015 | 169 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 18048 | 0.030 |
Why?
|
| Mental Processes | 1 | 2015 | 247 | 0.030 |
Why?
|
| Capsaicin | 1 | 2015 | 235 | 0.030 |
Why?
|
| Cell Survival | 2 | 2015 | 5801 | 0.030 |
Why?
|
| New England | 2 | 2008 | 1056 | 0.030 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2018 | 876 | 0.030 |
Why?
|
| Cortical Synchronization | 1 | 2014 | 78 | 0.030 |
Why?
|
| Sleep | 2 | 2022 | 4796 | 0.030 |
Why?
|
| Malpractice | 1 | 1998 | 561 | 0.030 |
Why?
|
| Tryptamines | 1 | 2014 | 93 | 0.030 |
Why?
|
| Tooth Extraction | 1 | 2015 | 229 | 0.030 |
Why?
|
| Skin Tests | 1 | 2015 | 639 | 0.030 |
Why?
|
| Arthritis | 1 | 1999 | 685 | 0.030 |
Why?
|
| Professional Competence | 1 | 1996 | 431 | 0.030 |
Why?
|
| Tooth, Impacted | 1 | 2013 | 40 | 0.030 |
Why?
|
| Data Collection | 3 | 2013 | 3329 | 0.030 |
Why?
|
| Antipruritics | 1 | 2012 | 31 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2007 | 3440 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2019 | 1510 | 0.030 |
Why?
|
| HIV Infections | 1 | 1999 | 17564 | 0.030 |
Why?
|
| Cultural Competency | 1 | 2015 | 303 | 0.020 |
Why?
|
| Sex Factors | 2 | 2019 | 10647 | 0.020 |
Why?
|
| Socioeconomic Factors | 3 | 2015 | 7863 | 0.020 |
Why?
|
| Uncertainty | 1 | 2017 | 758 | 0.020 |
Why?
|
| Models, Immunological | 1 | 2014 | 518 | 0.020 |
Why?
|
| Psychophysics | 1 | 2012 | 291 | 0.020 |
Why?
|
| Cell Movement | 2 | 2015 | 5223 | 0.020 |
Why?
|
| Forelimb | 1 | 2011 | 116 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 30028 | 0.020 |
Why?
|
| Statistics as Topic | 2 | 2010 | 2362 | 0.020 |
Why?
|
| Hand | 1 | 2017 | 907 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2018 | 2079 | 0.020 |
Why?
|
| Homozygote | 1 | 2016 | 1779 | 0.020 |
Why?
|
| Materia Medica | 1 | 2010 | 14 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2016 | 849 | 0.020 |
Why?
|
| Signal Detection, Psychological | 1 | 2011 | 84 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2014 | 591 | 0.020 |
Why?
|
| Europe | 1 | 1998 | 3439 | 0.020 |
Why?
|
| Multivariate Analysis | 3 | 2010 | 12096 | 0.020 |
Why?
|
| Animals | 4 | 2018 | 169418 | 0.020 |
Why?
|
| Lasers | 1 | 2015 | 952 | 0.020 |
Why?
|
| Anecdotes as Topic | 1 | 2010 | 56 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2015 | 552 | 0.020 |
Why?
|
| Electroencephalography | 2 | 2019 | 6309 | 0.020 |
Why?
|
| Affect | 1 | 2018 | 1498 | 0.020 |
Why?
|
| Hospitals | 2 | 2015 | 3906 | 0.020 |
Why?
|
| Risk Factors | 4 | 2016 | 74915 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2005 | 8538 | 0.020 |
Why?
|
| Vitamin E | 1 | 2014 | 873 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2018 | 1836 | 0.020 |
Why?
|
| Cell Line | 2 | 2015 | 15609 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2010 | 6879 | 0.020 |
Why?
|
| Nurses | 1 | 2019 | 2494 | 0.020 |
Why?
|
| Haplotypes | 1 | 2016 | 2725 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 1677 | 0.020 |
Why?
|
| Life Style | 1 | 2001 | 3929 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2011 | 8201 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2020 | 2427 | 0.020 |
Why?
|
| Pyridines | 1 | 2021 | 2888 | 0.020 |
Why?
|
| Age Factors | 2 | 2019 | 18478 | 0.020 |
Why?
|
| Health Literacy | 1 | 2015 | 467 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2011 | 450 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2016 | 3615 | 0.020 |
Why?
|
| Parkinsonian Disorders | 1 | 2011 | 285 | 0.020 |
Why?
|
| Cell Shape | 1 | 2010 | 371 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 13026 | 0.020 |
Why?
|
| Learning | 1 | 2018 | 1762 | 0.020 |
Why?
|
| Motion Perception | 1 | 2012 | 379 | 0.020 |
Why?
|
| Trust | 1 | 2013 | 532 | 0.020 |
Why?
|
| Triazoles | 1 | 2014 | 905 | 0.020 |
Why?
|
| Thalamus | 1 | 2014 | 1051 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2010 | 425 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2015 | 10494 | 0.020 |
Why?
|
| Crime Victims | 1 | 2012 | 347 | 0.020 |
Why?
|
| Judgment | 1 | 2010 | 273 | 0.020 |
Why?
|
| Boston | 2 | 2015 | 9361 | 0.020 |
Why?
|
| Total Quality Management | 1 | 2009 | 264 | 0.020 |
Why?
|
| Afferent Pathways | 1 | 2009 | 304 | 0.020 |
Why?
|
| Corpus Striatum | 1 | 2014 | 1238 | 0.020 |
Why?
|
| Nonprescription Drugs | 1 | 2008 | 119 | 0.020 |
Why?
|
| Behavior Therapy | 1 | 1993 | 885 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2018 | 4202 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2015 | 2942 | 0.020 |
Why?
|
| Prevalence | 1 | 2004 | 15880 | 0.020 |
Why?
|
| Magnetoencephalography | 1 | 2011 | 641 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 4572 | 0.020 |
Why?
|
| Disease Management | 1 | 2017 | 2533 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2015 | 2508 | 0.020 |
Why?
|
| Amygdala | 1 | 2014 | 1382 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 11930 | 0.020 |
Why?
|
| Language | 1 | 2015 | 1557 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2019 | 41797 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2009 | 3408 | 0.020 |
Why?
|
| Transportation | 1 | 2007 | 218 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2010 | 796 | 0.020 |
Why?
|
| Stroke | 2 | 2007 | 9791 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2003 | 5510 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2020 | 5103 | 0.020 |
Why?
|
| Reaction Time | 1 | 2012 | 2102 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2823 | 0.020 |
Why?
|
| Population | 1 | 2005 | 141 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 2009 | 588 | 0.010 |
Why?
|
| Muscle Spasticity | 1 | 2005 | 158 | 0.010 |
Why?
|
| Spirituality | 1 | 2009 | 430 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2010 | 1339 | 0.010 |
Why?
|
| Mass Media | 1 | 2007 | 304 | 0.010 |
Why?
|
| Rats | 2 | 2011 | 23839 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2003 | 5887 | 0.010 |
Why?
|
| Individuality | 1 | 2006 | 310 | 0.010 |
Why?
|
| Motor Skills | 1 | 2007 | 522 | 0.010 |
Why?
|
| Prescription Drugs | 1 | 2011 | 634 | 0.010 |
Why?
|
| Sensory Receptor Cells | 1 | 2009 | 508 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2006 | 1379 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2019 | 3431 | 0.010 |
Why?
|
| Probability | 1 | 2009 | 2483 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 4249 | 0.010 |
Why?
|
| Comorbidity | 2 | 2010 | 10601 | 0.010 |
Why?
|
| Hospital Departments | 1 | 2003 | 135 | 0.010 |
Why?
|
| MEDLINE | 1 | 2003 | 119 | 0.010 |
Why?
|
| Psychopathology | 1 | 2006 | 435 | 0.010 |
Why?
|
| Arizona | 1 | 2002 | 108 | 0.010 |
Why?
|
| Patient Preference | 1 | 2010 | 948 | 0.010 |
Why?
|
| Massachusetts | 2 | 2008 | 8908 | 0.010 |
Why?
|
| Incidence | 2 | 2014 | 21552 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2009 | 1882 | 0.010 |
Why?
|
| Connecticut | 1 | 2002 | 365 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2012 | 6035 | 0.010 |
Why?
|
| Washington | 1 | 2002 | 314 | 0.010 |
Why?
|
| Collagen | 1 | 2010 | 2646 | 0.010 |
Why?
|
| Cohort Effect | 1 | 2001 | 39 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2007 | 1670 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2009 | 2944 | 0.010 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2003 | 395 | 0.010 |
Why?
|
| Age Distribution | 1 | 2007 | 2881 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2016 | 12813 | 0.010 |
Why?
|
| Physicians, Family | 1 | 2002 | 349 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2001 | 617 | 0.010 |
Why?
|
| Logistic Models | 2 | 2009 | 13324 | 0.010 |
Why?
|
| History, Medieval | 1 | 1999 | 62 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 12561 | 0.010 |
Why?
|
| Employment | 1 | 2006 | 1120 | 0.010 |
Why?
|
| Program Development | 1 | 2005 | 1296 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2012 | 2518 | 0.010 |
Why?
|
| Range of Motion, Articular | 1 | 2005 | 1599 | 0.010 |
Why?
|
| Phenotype | 1 | 2016 | 16712 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 14158 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2000 | 1629 | 0.010 |
Why?
|
| Demography | 1 | 2002 | 1643 | 0.010 |
Why?
|
| Goals | 1 | 2003 | 715 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 15460 | 0.010 |
Why?
|
| Random Allocation | 1 | 2001 | 2399 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2007 | 2994 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1999 | 15880 | 0.010 |
Why?
|
| Workload | 1 | 2002 | 852 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2005 | 2433 | 0.010 |
Why?
|
| Health Services Research | 1 | 2002 | 1815 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2010 | 8081 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 12774 | 0.010 |
Why?
|
| United States Food and Drug Administration | 1 | 2003 | 1669 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2005 | 2526 | 0.010 |
Why?
|
| Faculty, Medical | 1 | 2003 | 1218 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 19041 | 0.010 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2012 | 4636 | 0.010 |
Why?
|
| Exercise Therapy | 1 | 2001 | 941 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2001 | 1839 | 0.010 |
Why?
|
| Forecasting | 1 | 2003 | 2950 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 8559 | 0.010 |
Why?
|
| Hypertension | 1 | 1993 | 8611 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 11674 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2000 | 4861 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2002 | 1946 | 0.010 |
Why?
|
| Students, Medical | 1 | 2003 | 1962 | 0.010 |
Why?
|
| Risk | 1 | 2001 | 9642 | 0.010 |
Why?
|
| General Surgery | 1 | 1999 | 1714 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 2001 | 5532 | 0.000 |
Why?
|
| Child, Preschool | 2 | 2000 | 42623 | 0.000 |
Why?
|
| Odds Ratio | 1 | 1999 | 9687 | 0.000 |
Why?
|
| Infant | 1 | 2000 | 36497 | 0.000 |
Why?
|